TY - JOUR
T1 - Prevalence of Brugada sign and syndrome in patients presenting with arrhythmic symptoms at a Heart Rhythm Clinic in Singapore
AU - Sidik, Novalia P.
AU - Quay, Chwee N.
AU - Loh, Fong C.
AU - Chen, Lin Y.
PY - 2009/5
Y1 - 2009/5
N2 - AimsSoutheast Asia is endemic for Brugada syndrome; however, its prevalence in Singapore is unknown. We aimed to determine the prevalence of Brugada sign [Types 1, 2, and 3 Brugada electrocardiogram (ECG)] and syndrome at an arrhythmia clinic in Singapore.Methods and resultsPatients who presented with pre-syncope, syncope, and/or palpitations without a known cause at an arrhythmia clinic between 2005 and 2007 were included in the study. The study criteria were met by 392 patients (age: 49.6 ± 19.1 years, 55.9 male); 675 patients were excluded because they were referred for the management of known diagnoses. The 12-lead ECGs of these patients were analysed and clinical information was abstracted. Brugada sign was observed in 28 patients, and 12 patients were determined to have Brugada syndrome (age: 36.3 ± 15.4 years, 100 male), yielding a prevalence of 7.1 [95 confidence interval (CI): 4.8-10.2] and 3.1 (95 CI: 1.6-5.3), respectively. The prevalence rates of patients with Type 1, Type 2, and Type 3 Brugada signs were 4.8 (95 CI: 2.9-7.5), 1.8 (95 CI: 0.7-3.6), and 0.5 (95 CI: 0.06-1.8), respectively. Over 30.4 person-years of follow-up, there was one inappropriate defibrillation shock but no appropriate shocks or sudden cardiac deaths among patients with Brugada sign or syndrome.ConclusionThe prevalence of both Brugada sign and syndrome in a hospital-based population in Singapore was found to be high. Further population-based investigation is warranted to confirm these findings.
AB - AimsSoutheast Asia is endemic for Brugada syndrome; however, its prevalence in Singapore is unknown. We aimed to determine the prevalence of Brugada sign [Types 1, 2, and 3 Brugada electrocardiogram (ECG)] and syndrome at an arrhythmia clinic in Singapore.Methods and resultsPatients who presented with pre-syncope, syncope, and/or palpitations without a known cause at an arrhythmia clinic between 2005 and 2007 were included in the study. The study criteria were met by 392 patients (age: 49.6 ± 19.1 years, 55.9 male); 675 patients were excluded because they were referred for the management of known diagnoses. The 12-lead ECGs of these patients were analysed and clinical information was abstracted. Brugada sign was observed in 28 patients, and 12 patients were determined to have Brugada syndrome (age: 36.3 ± 15.4 years, 100 male), yielding a prevalence of 7.1 [95 confidence interval (CI): 4.8-10.2] and 3.1 (95 CI: 1.6-5.3), respectively. The prevalence rates of patients with Type 1, Type 2, and Type 3 Brugada signs were 4.8 (95 CI: 2.9-7.5), 1.8 (95 CI: 0.7-3.6), and 0.5 (95 CI: 0.06-1.8), respectively. Over 30.4 person-years of follow-up, there was one inappropriate defibrillation shock but no appropriate shocks or sudden cardiac deaths among patients with Brugada sign or syndrome.ConclusionThe prevalence of both Brugada sign and syndrome in a hospital-based population in Singapore was found to be high. Further population-based investigation is warranted to confirm these findings.
KW - Brugada syndrome
KW - Brugada-type electrocardiogram
KW - Prevalence
KW - Southeast Asia
UR - http://www.scopus.com/inward/record.url?scp=66749173071&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=66749173071&partnerID=8YFLogxK
U2 - 10.1093/europace/eup079
DO - 10.1093/europace/eup079
M3 - Article
C2 - 19351631
AN - SCOPUS:66749173071
VL - 11
SP - 650
EP - 656
JO - Europace
JF - Europace
SN - 1099-5129
IS - 5
ER -